316 related articles for article (PubMed ID: 15548844)
21. In silico pKa prediction and ADME profiling.
Cruciani G; Milletti F; Storchi L; Sforna G; Goracci L
Chem Biodivers; 2009 Nov; 6(11):1812-21. PubMed ID: 19937818
[TBL] [Abstract][Full Text] [Related]
22. truPK -- human pharmacokinetic models for quantitative ADME prediction.
Subramanian K
Expert Opin Drug Metab Toxicol; 2005 Oct; 1(3):555-64. PubMed ID: 16863461
[TBL] [Abstract][Full Text] [Related]
23. QSAR and QM/MM approaches applied to drug metabolism prediction.
Braga RC; Andrade CH
Mini Rev Med Chem; 2012 Jun; 12(6):573-82. PubMed ID: 22587770
[TBL] [Abstract][Full Text] [Related]
24. Application of in silico approaches to predicting drug--drug interactions.
Ekins S; Wrighton SA
J Pharmacol Toxicol Methods; 2001; 45(1):65-9. PubMed ID: 11489666
[TBL] [Abstract][Full Text] [Related]
25. Predicting Human Pharmacokinetics: Physiologically Based Pharmacokinetic Modeling and In Silico ADME Prediction in Early Drug Discovery.
Shi J; Zha W
Eur J Drug Metab Pharmacokinet; 2019 Feb; 44(1):135-137. PubMed ID: 30136219
[No Abstract] [Full Text] [Related]
26. Characterisation of data resources for in silico modelling: benchmark datasets for ADME properties.
Przybylak KR; Madden JC; Covey-Crump E; Gibson L; Barber C; Patel M; Cronin MTD
Expert Opin Drug Metab Toxicol; 2018 Feb; 14(2):169-181. PubMed ID: 28375027
[TBL] [Abstract][Full Text] [Related]
27. In silico platform for xenobiotics ADME-T pharmacological properties modeling and prediction. Part II: The body in a Hilbertian space.
Jacob A; Pratuangdejkul J; Buffet S; Launay JM; Manivet P
Drug Discov Today; 2009 Apr; 14(7-8):406-12. PubMed ID: 19340930
[TBL] [Abstract][Full Text] [Related]
28. ADME-Space: a new tool for medicinal chemists to explore ADME properties.
Bocci G; Carosati E; Vayer P; Arrault A; Lozano S; Cruciani G
Sci Rep; 2017 Jul; 7(1):6359. PubMed ID: 28743970
[TBL] [Abstract][Full Text] [Related]
29. In vitro, in silico and integrated strategies for the estimation of plasma protein binding. A review.
Lambrinidis G; Vallianatou T; Tsantili-Kakoulidou A
Adv Drug Deliv Rev; 2015 Jun; 86():27-45. PubMed ID: 25819487
[TBL] [Abstract][Full Text] [Related]
30. Recent Advances of Computational Modeling for Predicting Drug Metabolism: A Perspective.
Kar S; Leszczynski J
Curr Drug Metab; 2017; 18(12):1106-1122. PubMed ID: 28595533
[TBL] [Abstract][Full Text] [Related]
31. Using in vitro human tissues to predict pharmacokinetic properties.
Huebert ND; Dasgupta M; Chen Y
Curr Opin Drug Discov Devel; 2004 Jan; 7(1):69-74. PubMed ID: 14982150
[TBL] [Abstract][Full Text] [Related]
32. The role of absorption, distribution, metabolism, excretion and toxicity in drug discovery.
Lin J; Sahakian DC; de Morais SM; Xu JJ; Polzer RJ; Winter SM
Curr Top Med Chem; 2003; 3(10):1125-54. PubMed ID: 12769713
[TBL] [Abstract][Full Text] [Related]
33. In silico prediction of ADME properties: are we making progress?
Beresford AP; Segall M; Tarbit MH
Curr Opin Drug Discov Devel; 2004 Jan; 7(1):36-42. PubMed ID: 14982146
[TBL] [Abstract][Full Text] [Related]
34. In Silico and Ex silico ADME approaches for drug discovery.
Darvas F; Keseru G; Papp A; Dormán G; Urge L; Krajcsi P
Curr Top Med Chem; 2002 Dec; 2(12):1287-304. PubMed ID: 12470281
[TBL] [Abstract][Full Text] [Related]
35. Quantitative structure/activity relationship modelling of pharmacokinetic properties using genetic algorithm-combined partial least squares method.
Yamashita F; Fujiwara S; Wanchana S; Hashida M
J Drug Target; 2006; 14(7):496-504. PubMed ID: 17062396
[TBL] [Abstract][Full Text] [Related]
36. From in vivo to in vitro/in silico ADME: progress and challenges.
Van de Waterbeemd H
Expert Opin Drug Metab Toxicol; 2005 Jun; 1(1):1-4. PubMed ID: 16922647
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic Tools and Applications.
Madden JC; Thompson CV
Methods Mol Biol; 2022; 2425():57-83. PubMed ID: 35188628
[TBL] [Abstract][Full Text] [Related]
38. Predicting ADME properties and side effects: the BioPrint approach.
Krejsa CM; Horvath D; Rogalski SL; Penzotti JE; Mao B; Barbosa F; Migeon JC
Curr Opin Drug Discov Devel; 2003 Jul; 6(4):470-80. PubMed ID: 12951810
[TBL] [Abstract][Full Text] [Related]
39. Implementation of an ADME enabling selection and visualization tool for drug discovery.
Stoner CL; Gifford E; Stankovic C; Lepsy CS; Brodfuehrer J; Prasad JV; Surendran N
J Pharm Sci; 2004 May; 93(5):1131-41. PubMed ID: 15067690
[TBL] [Abstract][Full Text] [Related]
40. Predicting human pharmacokinetics from preclinical data.
Poggesi I
Curr Opin Drug Discov Devel; 2004 Jan; 7(1):100-11. PubMed ID: 14982153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
